共 127 条
[1]
Siegel RL(2021)Cancer Statistics, 2021 CA Cancer J Clin 71 7-33
[2]
Miller KD(2009)Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features Proc Natl Acad Sci USA 106 13820-13825
[3]
Fuchs HE(2017)Role of RPL39 in metaplastic breast cancer J Natl Cancer Inst 109 djw292-8843
[4]
Creighton CJ(2014)Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling Proc Natl Acad Sci USA 111 8838-930
[5]
Li X(2016)An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model Genes Dev 30 918-12
[6]
Landis M(2017)Tumor-infiltrating lymphocytes are significantly associated with better overall survival and disease-free survival in triple-negative but not estrogen receptor-positive breast cancers Hum Pathol 64 7-36
[7]
Dave B(2017)Distinctions in breast tumor recurrence patterns post-therapy among racially distinct populations PLoS ONE 12 e0170095-245
[8]
Gonzalez DD(2015)High pathologic complete response in Her2-positive, early-stage breast cancer to a novel nonanthracycline neoadjuvant chemotherapy Clin Breast Cancer 15 31-3593
[9]
Liu ZB(2019)ER(+)/HER2(+) breast cancer has different metastatic patterns and better survival than ER(-)/HER2(+) breast cancer Clin Breast Cancer 19 236-24
[10]
Dave B(2020)Different breast cancer subtypes show different metastatic patterns: a study from a large public database Asian Pac J Cancer Prev 21 3587-679